Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with ...

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

The NHS is the world’s first health service to adopt a ‘blood test-first’ approach for diagnosing lung cancer.

Younger patients with lung cancer are more likely to have mutations that allow for targeted therapies, which can lead to more ...

Rapid advances in cancer treatment have benefited many people, but urgent change is needed in Canada's cancer care workforce ...

Researchers have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...

Merck (MRK) stock falls as the company withdraws U.S. marketing application for lung cancer therapy HER3-DXd developed with ...

Here are 9 signs of lung cancer that you shouldn’t ignore… “This could be feeling short of breath when doing activities that ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...